COVID-19-associated encephalitis or Creutzfeldt-Jakob disease: a case report.

IF 3.4 Q3 CLINICAL NEUROLOGY Neurodegenerative disease management Pub Date : 2022-02-01 Epub Date: 2021-12-02 DOI:10.2217/nmt-2021-0025
Gooya Tayyebi, Seyed Kazem Malakouti, Behnam Shariati, Leila Kamalzadeh
{"title":"COVID-19-associated encephalitis or Creutzfeldt-Jakob disease: a case report.","authors":"Gooya Tayyebi,&nbsp;Seyed Kazem Malakouti,&nbsp;Behnam Shariati,&nbsp;Leila Kamalzadeh","doi":"10.2217/nmt-2021-0025","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Accurate diagnosis and management of patients with rapidly progressive dementia may be challenging during the COVID-19 pandemic, which has negatively influenced the diagnostic performances, medical resource allocation and routine care for all non-COVID-19 diseases. <b>Case presentation:</b> We herein present a case of a 57-year-old male with rapidly progressive cognitive decline, headache, diplopia, myalgia, unsteady gait, aggression, depression, insomnia, hallucinations and delusions of persecution. COVID-19-associated encephalitis was briefly considered as a differential diagnosis. However, this hypothesis was rejected upon further investigation. A final diagnosis of sporadic Creutzfeldt-Jakob disease was made. <b>Conclusion:</b> A timely and accurate diagnosis of Creutzfeldt-Jakob disease gives patients and their families the chance to receive a good standard of healthcare and avoid extensive evaluations for other conditions.</p>","PeriodicalId":19114,"journal":{"name":"Neurodegenerative disease management","volume":"12 1","pages":"29-34"},"PeriodicalIF":3.4000,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765092/pdf/","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurodegenerative disease management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/nmt-2021-0025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/12/2 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 8

Abstract

Background: Accurate diagnosis and management of patients with rapidly progressive dementia may be challenging during the COVID-19 pandemic, which has negatively influenced the diagnostic performances, medical resource allocation and routine care for all non-COVID-19 diseases. Case presentation: We herein present a case of a 57-year-old male with rapidly progressive cognitive decline, headache, diplopia, myalgia, unsteady gait, aggression, depression, insomnia, hallucinations and delusions of persecution. COVID-19-associated encephalitis was briefly considered as a differential diagnosis. However, this hypothesis was rejected upon further investigation. A final diagnosis of sporadic Creutzfeldt-Jakob disease was made. Conclusion: A timely and accurate diagnosis of Creutzfeldt-Jakob disease gives patients and their families the chance to receive a good standard of healthcare and avoid extensive evaluations for other conditions.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
covid -19相关脑炎或克雅氏病1例报告
背景:COVID-19大流行期间,快速进展性痴呆患者的准确诊断和管理可能具有挑战性,这对所有非COVID-19疾病的诊断性能、医疗资源分配和常规护理产生了负面影响。病例介绍:我们在此报告一例57岁男性患者,其表现为认知能力快速进行性下降、头痛、复视、肌痛、步态不稳、攻击性、抑郁、失眠、幻觉和迫害妄想。与covid -19相关的脑炎曾被短暂视为鉴别诊断。然而,经过进一步的调查,这一假设被否定了。最后诊断为散发性克雅氏病。结论:克雅氏病的及时准确诊断使患者及其家属有机会接受良好的医疗保健,避免对其他疾病进行广泛的评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
4.30
自引率
0.00%
发文量
35
期刊最新文献
"What about me? I'm supposed to be … superhuman?": exploring staff perspectives on how to deliver high quality psychological care for people living with amyotrophic lateral sclerosis. Patient and caregiver attitudes to cognitive and behavioral testing in Amyotrophic Lateral Sclerosis. Punding in dementia: an insight into its occurrence, clinical characteristics, treatment, and outcome. Management of glaucoma as a neurodegenerative disease. The therapeutic potential of laquinimod for Huntington's disease: A systematic review of preclinical and clinical studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1